Detailed Information on Publication Record
2003
Combined treatment with methamphetamine and fluoxetine influences pharmacokinetic behaviour of dextromethorphane in the rat
DOSTÁLEK, Miroslav, Jiří SLÍVA, Eva HADAŠOVÁ and Josef TOMANDLBasic information
Original name
Combined treatment with methamphetamine and fluoxetine influences pharmacokinetic behaviour of dextromethorphane in the rat
Name in Czech
Vliv fluoxetinu na biotransformacní procesy metamfetaminu
Authors
DOSTÁLEK, Miroslav (203 Czech Republic), Jiří SLÍVA (203 Czech Republic), Eva HADAŠOVÁ (203 Czech Republic, guarantor) and Josef TOMANDL (203 Czech Republic)
Edition
Psychiatrie, Praha, Tigis s.r.o. 2003, 1211-7579
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/03:00009239
Organization unit
Faculty of Medicine
Keywords in English
methamphetamine; pharmacokinetics; dextromethorphan
Změněno: 31/5/2005 10:38, PharmDr. Miroslav Dostálek, Ph.D.
V originále
The purpose of this study was to assess pharmacokinetics of dextromethorphane (model substrate of CYP2D2). The results suggest that fluoxetine therapy in methamphetamine dependece could slow down biodegradation of methamphetamine and this would enable to reduce methamphetamine doses without a decrease in psychotropic effect of drug.
In Czech
The purpose of this study was to assess pharmacokinetics of dextromethorphane (model substrate of CYP2D2). The results suggest that fluoxetine therapy in methamphetamine dependece could slow down biodegradation of methamphetamine and this would enable to reduce methamphetamine doses without a decrease in psychotropic effect of drug.